nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxazepam—GABRA3—Graves' disease	0.817	1	CbGaD
Oxazepam—GABRQ—GABA A receptor activation—GABRA3—Graves' disease	0.00469	0.0406	CbGpPWpGaD
Oxazepam—GABRG3—GABA A receptor activation—GABRA3—Graves' disease	0.00387	0.0334	CbGpPWpGaD
Oxazepam—GABRB1—GABA A receptor activation—GABRA3—Graves' disease	0.00381	0.0329	CbGpPWpGaD
Oxazepam—Drowsiness—Methimazole—Graves' disease	0.00366	0.0661	CcSEcCtD
Oxazepam—GABRA6—GABA A receptor activation—GABRA3—Graves' disease	0.0036	0.0311	CbGpPWpGaD
Oxazepam—Jaundice—Methimazole—Graves' disease	0.00357	0.0645	CcSEcCtD
Oxazepam—GABRA4—GABA A receptor activation—GABRA3—Graves' disease	0.00356	0.0307	CbGpPWpGaD
Oxazepam—Agranulocytosis—Methimazole—Graves' disease	0.00342	0.0617	CcSEcCtD
Oxazepam—GABRB2—GABA A receptor activation—GABRA3—Graves' disease	0.00325	0.0281	CbGpPWpGaD
Oxazepam—GABRA5—GABA A receptor activation—GABRA3—Graves' disease	0.00316	0.0273	CbGpPWpGaD
Oxazepam—Drowsiness—Propylthiouracil—Graves' disease	0.00311	0.0562	CcSEcCtD
Oxazepam—GABRA2—GABA A receptor activation—GABRA3—Graves' disease	0.00305	0.0264	CbGpPWpGaD
Oxazepam—Jaundice—Propylthiouracil—Graves' disease	0.00303	0.0548	CcSEcCtD
Oxazepam—GABRB3—GABA A receptor activation—GABRA3—Graves' disease	0.00303	0.0262	CbGpPWpGaD
Oxazepam—GABRR1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00301	0.026	CbGpPWpGaD
Oxazepam—GABRG2—GABA A receptor activation—GABRA3—Graves' disease	0.00298	0.0257	CbGpPWpGaD
Oxazepam—Agranulocytosis—Propylthiouracil—Graves' disease	0.00291	0.0525	CcSEcCtD
Oxazepam—GABRQ—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00287	0.0248	CbGpPWpGaD
Oxazepam—GABRR2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00287	0.0248	CbGpPWpGaD
Oxazepam—GABRA1—GABA A receptor activation—GABRA3—Graves' disease	0.0026	0.0225	CbGpPWpGaD
Oxazepam—Vertigo—Methimazole—Graves' disease	0.00257	0.0464	CcSEcCtD
Oxazepam—Leukopenia—Methimazole—Graves' disease	0.00256	0.0463	CcSEcCtD
Oxazepam—GABRG3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00237	0.0205	CbGpPWpGaD
Oxazepam—Oedema—Methimazole—Graves' disease	0.00234	0.0422	CcSEcCtD
Oxazepam—GABRB1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00233	0.0201	CbGpPWpGaD
Oxazepam—GABRA6—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00221	0.0191	CbGpPWpGaD
Oxazepam—Vertigo—Propylthiouracil—Graves' disease	0.00219	0.0395	CcSEcCtD
Oxazepam—GABRA4—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00218	0.0188	CbGpPWpGaD
Oxazepam—Leukopenia—Propylthiouracil—Graves' disease	0.00218	0.0393	CcSEcCtD
Oxazepam—Paraesthesia—Methimazole—Graves' disease	0.0021	0.0379	CcSEcCtD
Oxazepam—Somnolence—Methimazole—Graves' disease	0.00208	0.0375	CcSEcCtD
Oxazepam—GABRB2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00199	0.0172	CbGpPWpGaD
Oxazepam—Oedema—Propylthiouracil—Graves' disease	0.00199	0.0359	CcSEcCtD
Oxazepam—GABRA5—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00194	0.0167	CbGpPWpGaD
Oxazepam—GABRA2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00187	0.0161	CbGpPWpGaD
Oxazepam—GABRB3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00186	0.016	CbGpPWpGaD
Oxazepam—Body temperature increased—Methimazole—Graves' disease	0.00185	0.0333	CcSEcCtD
Oxazepam—GABRG2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00182	0.0157	CbGpPWpGaD
Oxazepam—Paraesthesia—Propylthiouracil—Graves' disease	0.00178	0.0322	CcSEcCtD
Oxazepam—Somnolence—Propylthiouracil—Graves' disease	0.00177	0.0319	CcSEcCtD
Oxazepam—GABRR1—GABA receptor activation—GABRA3—Graves' disease	0.0016	0.0138	CbGpPWpGaD
Oxazepam—GABRA1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00159	0.0138	CbGpPWpGaD
Oxazepam—Body temperature increased—Propylthiouracil—Graves' disease	0.00157	0.0283	CcSEcCtD
Oxazepam—GABRQ—GABA receptor activation—GABRA3—Graves' disease	0.00152	0.0132	CbGpPWpGaD
Oxazepam—GABRR2—GABA receptor activation—GABRA3—Graves' disease	0.00152	0.0132	CbGpPWpGaD
Oxazepam—Rash—Methimazole—Graves' disease	0.00147	0.0266	CcSEcCtD
Oxazepam—Dermatitis—Methimazole—Graves' disease	0.00147	0.0266	CcSEcCtD
Oxazepam—Headache—Methimazole—Graves' disease	0.00146	0.0264	CcSEcCtD
Oxazepam—Nausea—Methimazole—Graves' disease	0.00139	0.025	CcSEcCtD
Oxazepam—GABRG3—GABA receptor activation—GABRA3—Graves' disease	0.00126	0.0109	CbGpPWpGaD
Oxazepam—Rash—Propylthiouracil—Graves' disease	0.00125	0.0226	CcSEcCtD
Oxazepam—Dermatitis—Propylthiouracil—Graves' disease	0.00125	0.0226	CcSEcCtD
Oxazepam—Headache—Propylthiouracil—Graves' disease	0.00124	0.0225	CcSEcCtD
Oxazepam—GABRB1—GABA receptor activation—GABRA3—Graves' disease	0.00124	0.0107	CbGpPWpGaD
Oxazepam—Nausea—Propylthiouracil—Graves' disease	0.00118	0.0213	CcSEcCtD
Oxazepam—GABRA6—GABA receptor activation—GABRA3—Graves' disease	0.00117	0.0101	CbGpPWpGaD
Oxazepam—GABRA4—GABA receptor activation—GABRA3—Graves' disease	0.00116	0.00999	CbGpPWpGaD
Oxazepam—GABRB2—GABA receptor activation—GABRA3—Graves' disease	0.00106	0.00913	CbGpPWpGaD
Oxazepam—GABRA5—GABA receptor activation—GABRA3—Graves' disease	0.00103	0.00887	CbGpPWpGaD
Oxazepam—GABRA2—GABA receptor activation—GABRA3—Graves' disease	0.000991	0.00856	CbGpPWpGaD
Oxazepam—GABRB3—GABA receptor activation—GABRA3—Graves' disease	0.000985	0.00851	CbGpPWpGaD
Oxazepam—GABRG2—GABA receptor activation—GABRA3—Graves' disease	0.000967	0.00835	CbGpPWpGaD
Oxazepam—GABRQ—Orphan transporters—GABRA3—Graves' disease	0.000889	0.00769	CbGpPWpGaD
Oxazepam—GABRA1—GABA receptor activation—GABRA3—Graves' disease	0.000845	0.0073	CbGpPWpGaD
Oxazepam—Bromazepam—GABRA3—Graves' disease	0.000741	0.0854	CrCbGaD
Oxazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000735	0.00635	CbGpPWpGaD
Oxazepam—GABRG3—Orphan transporters—GABRA3—Graves' disease	0.000732	0.00633	CbGpPWpGaD
Oxazepam—GABRB1—Orphan transporters—GABRA3—Graves' disease	0.000721	0.00623	CbGpPWpGaD
Oxazepam—Chlordiazepoxide—GABRA3—Graves' disease	0.000719	0.0829	CrCbGaD
Oxazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000701	0.00606	CbGpPWpGaD
Oxazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000701	0.00606	CbGpPWpGaD
Oxazepam—Clonazepam—GABRA3—Graves' disease	0.000695	0.0801	CrCbGaD
Oxazepam—GABRA6—Orphan transporters—GABRA3—Graves' disease	0.000683	0.0059	CbGpPWpGaD
Oxazepam—GABRA4—Orphan transporters—GABRA3—Graves' disease	0.000674	0.00582	CbGpPWpGaD
Oxazepam—Clorazepate—GABRA3—Graves' disease	0.000673	0.0775	CrCbGaD
Oxazepam—GABRR1—Ion channel transport—GABRA3—Graves' disease	0.000654	0.00565	CbGpPWpGaD
Oxazepam—GABRQ—Ion channel transport—GABRA3—Graves' disease	0.000624	0.00539	CbGpPWpGaD
Oxazepam—GABRR2—Ion channel transport—GABRA3—Graves' disease	0.000624	0.00539	CbGpPWpGaD
Oxazepam—GABRB2—Orphan transporters—GABRA3—Graves' disease	0.000616	0.00533	CbGpPWpGaD
Oxazepam—Alprazolam—GABRA3—Graves' disease	0.000609	0.0702	CrCbGaD
Oxazepam—GABRA5—Orphan transporters—GABRA3—Graves' disease	0.000599	0.00518	CbGpPWpGaD
Oxazepam—Cinolazepam—GABRA3—Graves' disease	0.000594	0.0684	CrCbGaD
Oxazepam—GABRA2—Orphan transporters—GABRA3—Graves' disease	0.000578	0.00499	CbGpPWpGaD
Oxazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000577	0.00499	CbGpPWpGaD
Oxazepam—GABRB3—Orphan transporters—GABRA3—Graves' disease	0.000574	0.00496	CbGpPWpGaD
Oxazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000569	0.00491	CbGpPWpGaD
Oxazepam—GABRG2—Orphan transporters—GABRA3—Graves' disease	0.000564	0.00487	CbGpPWpGaD
Oxazepam—GABRR1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000552	0.00477	CbGpPWpGaD
Oxazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000538	0.00465	CbGpPWpGaD
Oxazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000531	0.00459	CbGpPWpGaD
Oxazepam—GABRR2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000527	0.00455	CbGpPWpGaD
Oxazepam—GABRQ—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000527	0.00455	CbGpPWpGaD
Oxazepam—Estazolam—GABRA3—Graves' disease	0.000522	0.0601	CrCbGaD
Oxazepam—GABRG3—Ion channel transport—GABRA3—Graves' disease	0.000514	0.00444	CbGpPWpGaD
Oxazepam—Halazepam—GABRA3—Graves' disease	0.000507	0.0584	CrCbGaD
Oxazepam—GABRB1—Ion channel transport—GABRA3—Graves' disease	0.000506	0.00437	CbGpPWpGaD
Oxazepam—Nitrazepam—GABRA3—Graves' disease	0.000504	0.058	CrCbGaD
Oxazepam—Adinazolam—GABRA3—Graves' disease	0.000497	0.0572	CrCbGaD
Oxazepam—GABRA1—Orphan transporters—GABRA3—Graves' disease	0.000493	0.00426	CbGpPWpGaD
Oxazepam—Fludiazepam—GABRA3—Graves' disease	0.000492	0.0567	CrCbGaD
Oxazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000486	0.0042	CbGpPWpGaD
Oxazepam—Prazepam—GABRA3—Graves' disease	0.00048	0.0553	CrCbGaD
Oxazepam—GABRA6—Ion channel transport—GABRA3—Graves' disease	0.000479	0.00414	CbGpPWpGaD
Oxazepam—GABRA4—Ion channel transport—GABRA3—Graves' disease	0.000473	0.00409	CbGpPWpGaD
Oxazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000472	0.00408	CbGpPWpGaD
Oxazepam—GABRR3—eye—Graves' disease	0.000458	0.119	CbGeAlD
Oxazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000456	0.00394	CbGpPWpGaD
Oxazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000453	0.00391	CbGpPWpGaD
Oxazepam—Triazolam—GABRA3—Graves' disease	0.000447	0.0515	CrCbGaD
Oxazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000444	0.00384	CbGpPWpGaD
Oxazepam—GABRG3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000434	0.00375	CbGpPWpGaD
Oxazepam—GABRB2—Ion channel transport—GABRA3—Graves' disease	0.000432	0.00374	CbGpPWpGaD
Oxazepam—Temazepam—GABRA3—Graves' disease	0.000428	0.0493	CrCbGaD
Oxazepam—GABRB1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000428	0.00369	CbGpPWpGaD
Oxazepam—GABRR1—Neuronal System—GABRA3—Graves' disease	0.000423	0.00366	CbGpPWpGaD
Oxazepam—GABRA5—Ion channel transport—GABRA3—Graves' disease	0.00042	0.00363	CbGpPWpGaD
Oxazepam—Midazolam—GABRA3—Graves' disease	0.000415	0.0478	CrCbGaD
Oxazepam—GABRA2—Ion channel transport—GABRA3—Graves' disease	0.000405	0.0035	CbGpPWpGaD
Oxazepam—GABRA6—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000405	0.0035	CbGpPWpGaD
Oxazepam—GABRQ—Neuronal System—GABRA3—Graves' disease	0.000404	0.00349	CbGpPWpGaD
Oxazepam—GABRR2—Neuronal System—GABRA3—Graves' disease	0.000404	0.00349	CbGpPWpGaD
Oxazepam—GABRB3—Ion channel transport—GABRA3—Graves' disease	0.000403	0.00348	CbGpPWpGaD
Oxazepam—GABRA4—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000399	0.00345	CbGpPWpGaD
Oxazepam—GABRR2—eye—Graves' disease	0.000397	0.103	CbGeAlD
Oxazepam—GABRG2—Ion channel transport—GABRA3—Graves' disease	0.000395	0.00342	CbGpPWpGaD
Oxazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000388	0.00336	CbGpPWpGaD
Oxazepam—GABRR1—eye—Graves' disease	0.000382	0.0996	CbGeAlD
Oxazepam—GABRB2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000365	0.00316	CbGpPWpGaD
Oxazepam—Diazepam—GABRA3—Graves' disease	0.000356	0.041	CrCbGaD
Oxazepam—GABRA5—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000355	0.00307	CbGpPWpGaD
Oxazepam—GABRA1—Ion channel transport—GABRA3—Graves' disease	0.000346	0.00299	CbGpPWpGaD
Oxazepam—GABRA2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000343	0.00296	CbGpPWpGaD
Oxazepam—GABRB3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00034	0.00294	CbGpPWpGaD
Oxazepam—GABRG2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000334	0.00289	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—GABRA3—Graves' disease	0.000333	0.00287	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—GABRA3—Graves' disease	0.000328	0.00283	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—GABRA3—Graves' disease	0.00031	0.00268	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—GABRA3—Graves' disease	0.000306	0.00264	CbGpPWpGaD
Oxazepam—GABRG3—pituitary gland—Graves' disease	0.000298	0.0776	CbGeAlD
Oxazepam—GABRA1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000292	0.00252	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—GABRA3—Graves' disease	0.00028	0.00242	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—GABRA3—Graves' disease	0.000272	0.00235	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—GABRA3—Graves' disease	0.000262	0.00227	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—GABRA3—Graves' disease	0.000261	0.00225	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—GABRA3—Graves' disease	0.000256	0.00221	CbGpPWpGaD
Oxazepam—GABRB1—pituitary gland—Graves' disease	0.00023	0.06	CbGeAlD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	0.000228	0.00197	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000228	0.00197	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—GABRA3—Graves' disease	0.000224	0.00193	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000217	0.00188	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000217	0.00188	CbGpPWpGaD
Oxazepam—GABRA4—pituitary gland—Graves' disease	0.000208	0.0541	CbGeAlD
Oxazepam—GABRP—pituitary gland—Graves' disease	0.000206	0.0537	CbGeAlD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—Graves' disease	0.000203	0.00176	CbGpPWpGaD
Oxazepam—GABRA3—thyroid gland—Graves' disease	0.000184	0.0479	CbGeAlD
Oxazepam—GABRB3—eye—Graves' disease	0.00018	0.0468	CbGeAlD
Oxazepam—UGT2B15—Metabolism—GC—Graves' disease	0.000179	0.00155	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000179	0.00155	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000176	0.00152	CbGpPWpGaD
Oxazepam—GABRG2—pituitary gland—Graves' disease	0.000174	0.0453	CbGeAlD
Oxazepam—GABRB3—connective tissue—Graves' disease	0.000173	0.0451	CbGeAlD
Oxazepam—GABRA6—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000167	0.00144	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000165	0.00142	CbGpPWpGaD
Oxazepam—GABRA2—adipose tissue—Graves' disease	0.000158	0.0412	CbGeAlD
Oxazepam—GABRE—pituitary gland—Graves' disease	0.000157	0.041	CbGeAlD
Oxazepam—GABRE—adipose tissue—Graves' disease	0.000157	0.0408	CbGeAlD
Oxazepam—GABRB2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00015	0.0013	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000149	0.00129	CbGpPWpGaD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	0.000147	0.00127	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000146	0.00126	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000141	0.00122	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00014	0.00121	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—GC—Graves' disease	0.000138	0.0012	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000138	0.00119	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—B3GNT2—Graves' disease	0.000136	0.00117	CbGpPWpGaD
Oxazepam—GABRE—thyroid gland—Graves' disease	0.000136	0.0354	CbGeAlD
Oxazepam—GABRB3—pituitary gland—Graves' disease	0.000133	0.0348	CbGeAlD
Oxazepam—GABRA1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00012	0.00104	CbGpPWpGaD
Oxazepam—GABRB3—thyroid gland—Graves' disease	0.000115	0.03	CbGeAlD
Oxazepam—CYP3A43—Metabolism—B3GNT2—Graves' disease	0.000105	0.000906	CbGpPWpGaD
Oxazepam—CYP3A5—adipose tissue—Graves' disease	9.06e-05	0.0236	CbGeAlD
Oxazepam—UGT2B7—Metabolism—GC—Graves' disease	8.16e-05	0.000705	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—Graves' disease	6.99e-05	0.000604	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GC—Graves' disease	6.63e-05	0.000573	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—B3GNT2—Graves' disease	6.18e-05	0.000534	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GC—Graves' disease	5.57e-05	0.000482	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—TNF—Graves' disease	5.08e-05	0.000439	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—B3GNT2—Graves' disease	5.02e-05	0.000434	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—B3GNT2—Graves' disease	4.22e-05	0.000365	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GC—Graves' disease	4.03e-05	0.000348	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—B3GNT2—Graves' disease	3.05e-05	0.000264	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GC—Graves' disease	1.87e-05	0.000162	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—B3GNT2—Graves' disease	1.42e-05	0.000123	CbGpPWpGaD
